Joakim Wijkstrom - 22 Aug 2022 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: SVP, Chief Marketing Officer
Signature: /s/ Joakim Wijkstrom
Issuer symbol: VNDA
Transactions as of: 22 Aug 2022
Net transactions value: -$37,007
Form type: 4
Filing time: 23 Aug 2022, 17:01:55 UTC
Previous filing: 02 Mar 2022
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Sale	$37,007	-3,605	-3.6%	$10.27	96,673	22 Aug 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

Content

Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.